Purification of recombinant histidine-tag streptolysin O using immobilized metal affinity expanded bed adsorption (IMA-EBA).

Int J Biol Macromol

Departament de Bioquímica i Biologia Molecular, Unitat de Bioquímica de Medicina, Universitat Autònoma de Barcelona, Edifici M, 08193 Bellaterra, Barcelona, Spain.

Published: March 2006


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In this report, we describe the recombinant SLO expression as a fusion protein with a C-terminal hexahistidine tag and its purification using immobilized metal affinity expanded bed adsorption (STREAMLINE(trade mark) Chelating). In order to facilitate downstream processing of the purification, an efficient fermentation process was developed focusing on the achievement of high yields of soluble protein. The purification strategy resulted in a 40% recovery of active recombinant SLO and the protein was purified eight-fold. SDS-PAGE and Western-blot analysis of the purified protein revealed the presence of a 75 Mr form, which was the estimated relative Mass of the recombinant SLO.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2006.02.005DOI Listing

Publication Analysis

Top Keywords

recombinant slo
12
immobilized metal
8
metal affinity
8
affinity expanded
8
expanded bed
8
bed adsorption
8
purification
4
purification recombinant
4
recombinant histidine-tag
4
histidine-tag streptolysin
4

Similar Publications

Small molecules like PLX5622 for microglia depletion and Tamoxifen for inducible Cre recombination are commonly used in mouse research. Traditional application methods, such as chow or oral gavage and injections, have limitations, including uncontrolled dosage and risk of injury. To address this issue, we have developed an alternative oral drug delivery system using a gel-based rodent maintenance diet that allows for controlled consumption and adjustment of dosage and is suitable for water-insoluble small molecules.

View Article and Find Full Text PDF

A high-throughput target-based screening approach for the identification and assessment of mycothione reductase inhibitors.

Microbiol Spectr

March 2024

Laboratory of Microbiology, Parasitology and Hygiene, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium.

Unlabelled: The World Health Organization's goal to combat tuberculosis (TB) is hindered by the emergence of anti-microbial resistance, therefore necessitating the exploration of new drug targets. Multidrug regimens are indispensable in TB therapy as they provide synergetic bactericidal effects, shorten treatment duration, and reduce the risk of resistance development. The research within our European RespiriTB consortium explores energy metabolism to identify new drug candidates that synergize with bedaquiline, with the aim of discovering more efficient combination drug regimens.

View Article and Find Full Text PDF

Background: Monkeypox Virus (MPV) is the cause of zoonotic disease characterized by skin-eruption with pus cell formation and lymphadenopathy. This virus belongs to the Orthopoxvirus genus with DNA as its genetic material. Previously, this infection was reported from Africa and occasionally from USA and UK.

View Article and Find Full Text PDF
Article Synopsis
  • Planarians are being studied for their ability to regenerate, with new tools for expressing non-native proteins proving to be valuable for research.
  • The study utilizes a luminescent reporter to avoid the strong autofluorescence in planarian tissues, facilitating the introduction and measurement of mRNA in living planarians.
  • By modifying untranslated regions (UTRs) and investigating protein expression, this research lays the groundwork for understanding gene regulation and enhances methods for using planarians in genetic studies.
View Article and Find Full Text PDF

An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials.

Int J Mol Sci

April 2022

CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), C/Monforte de Lemos 3-5, 28029 Madrid, Spain.

Under the need for new functional and biocompatible materials for biomedical applications, protein engineering allows the design of assemblable polypeptides, which, as convenient building blocks of supramolecular complexes, can be produced in recombinant cells by simple and scalable methodologies. However, the stability of such materials is often overlooked or disregarded, becoming a potential bottleneck in the development and viability of novel products. In this context, we propose a design strategy based on in silico tools to detect instability areas in protein materials and to facilitate the decision making in the rational mutagenesis aimed to increase their stability and solubility.

View Article and Find Full Text PDF